NeoGenomics (NEO) CEO Chris Smith to retire
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Raymond James Reiterates Market Perform Rating on Neogenomics (NEO) 'in light of the moving parts'
January 10, 2025 1:00 PM ESTRaymond James analyst Andrew Cooper reiterated a Market Perform rating and {REMOVEPT} price target on Neogenomics (NASDAQ: NEO)
The analyst comments "This morning, NeoGenomics announced the retirement of current CEO Chris Smith, naming board member Tony Zook as his successor effective the start of 2Q. The company also reaffirmed its 2024 guidance as part of the release. The retirement is somewhat of a surprise, but comes after a near double move since announcement of Smiths appointment and nearly... More
